Nuveen Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $66.2M | Sell |
1,006,922
-215,973
| -18% | -$14.2M | 0.02% | 531 |
|
|
2024
Q3 | $86M | Buy |
1,222,895
+161,293
| +15% | +$11.3M | 0.02% | 460 |
|
|
2024
Q2 | $87.4M | Buy |
1,061,602
+207,210
| +24% | +$17.1M | 0.03% | 443 |
|
|
2024
Q1 | $74.6M | Buy |
854,392
+242,978
| +40% | +$21.2M | 0.02% | 499 |
|
|
2023
Q4 | $59M | Buy |
611,414
+34,905
| +6% | +$3.37M | 0.02% | 546 |
|
|
2023
Q3 | $51M | Sell |
576,509
-14,708
| -2% | -$1.3M | 0.02% | 558 |
|
|
2023
Q2 | $51.2M | Buy |
591,217
+4,922
| +0.8% | +$427K | 0.02% | 565 |
|
|
2023
Q1 | $57M | Buy |
586,295
+30,890
| +6% | +$3M | 0.02% | 498 |
|
|
2022
Q4 | $57.5M | Sell |
555,405
-82,857
| -13% | -$8.57M | 0.02% | 496 |
|
|
2022
Q3 | $54.1M | Sell |
638,262
-4,807
| -0.7% | -$407K | 0.02% | 506 |
|
|
2022
Q2 | $53.3M | Sell |
643,069
-30,907
| -5% | -$2.56M | 0.02% | 523 |
|
|
2022
Q1 | $54.7M | Sell |
673,976
-123,756
| -16% | -$10M | 0.02% | 606 |
|
|
2021
Q4 | $70.5M | Sell |
797,732
-15,422
| -2% | -$1.36M | 0.02% | 536 |
|
|
2021
Q3 | $62.8M | Sell |
813,154
-169,862
| -17% | -$13.1M | 0.02% | 576 |
|
|
2021
Q2 | $82M | Sell |
983,016
-440,648
| -31% | -$36.8M | 0.02% | 539 |
|
|
2021
Q1 | $108M | Sell |
1,423,664
-60,324
| -4% | -$4.56M | 0.03% | 442 |
|
|
2020
Q4 | $130M | Sell |
1,483,988
-532,329
| -26% | -$46.7M | 0.04% | 367 |
|
|
2020
Q3 | $153M | Sell |
2,016,317
-1,072,692
| -35% | -$81.6M | 0.06% | 269 |
|
|
2020
Q2 | $381M | Buy |
3,089,009
+1,269,435
| +70% | +$157M | 0.16% | 125 |
|
|
2020
Q1 | $154M | Buy |
1,819,574
+961,494
| +112% | +$81.2M | 0.07% | 235 |
|
|
2019
Q4 | $72.6M | Sell |
858,080
-421,396
| -33% | -$35.6M | 0.03% | 521 |
|
|
2019
Q3 | $86.2M | Sell |
1,279,476
-1,733,420
| -58% | -$117M | 0.03% | 439 |
|
|
2019
Q2 | $258M | Buy |
+3,012,896
| New | +$258M | 0.1% | 203 |
|
|
2018
Q2 | – | Sell |
-3,554
| Closed | -$288K | – | 1035 |
|
|
2018
Q1 | $288K | Sell |
3,554
-416
| -10% | -$33.7K | ﹤0.01% | 982 |
|
|
2017
Q4 | $354K | Buy |
+3,970
| New | +$354K | ﹤0.01% | 949 |
|
|
2017
Q1 | – | Sell |
-113,937
| Closed | -$9.44M | – | 1370 |
|
|
2016
Q4 | $9.44M | Buy |
113,937
+33,943
| +42% | +$2.81M | 0.05% | 476 |
|
|
2016
Q3 | $7.4M | Buy |
+79,994
| New | +$7.4M | 0.04% | 458 |
|
|
2015
Q4 | – | Sell |
-55,653
| Closed | -$5.86K | – | 1432 |
|
|
2015
Q3 | $5.86K | Sell |
55,653
-38,972
| -41% | -$4.1K | 0.03% | 446 |
|
|
2015
Q2 | $12.9K | Buy |
94,625
+82,491
| +680% | +$11.3K | 0.07% | 327 |
|
|
2015
Q1 | $1.51M | Sell |
12,134
-207
| -2% | -$25.8K | 0.01% | 949 |
|
|
2014
Q4 | $1.12M | Hold |
12,341
| – | – | 0.01% | 1077 |
|
|
2014
Q3 | $891K | Sell |
12,341
-340
| -3% | -$24.5K | 0.01% | 1127 |
|
|
2014
Q2 | $789K | Sell |
12,681
-199
| -2% | -$12.4K | ﹤0.01% | 1207 |
|
|
2014
Q1 | $879K | Buy |
12,880
+867
| +7% | +$59.2K | 0.01% | 1136 |
|
|
2013
Q4 | $845K | Sell |
12,013
-20,260
| -63% | -$1.43M | 0.01% | 1105 |
|
|
2013
Q3 | $2.33M | Buy |
32,273
+20,260
| +169% | +$1.46M | 0.02% | 668 |
|
|
2013
Q2 | $670K | Buy |
+12,013
| New | +$670K | ﹤0.01% | 1151 |
|